Zenbise Tablet
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Jeongwoo Pharmaceutical Co., Ltd.
MFDS item code 201904406 · Approved 2019.06.27
This product's status changed to Expired on 2024.06.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastrointestinal disorders (such as ulcers, gastritis, and gastroesophageal reflux disease); prevention of Mendelson syndrome
This medication is effective for gastrointestinal diseases such as gastric and duodenal ulcers, gastritis, and gastroesophageal reflux disease. It is also used to treat conditions related to excessive gastric acid secretion, such as Zollinger-Ellison syndrome. It may be administered to prevent Mendelson's syndrome during pre-operative anesthesia and is helpful in preventing ulcers post-surgery. It is also used to treat gastric and duodenal ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs). This medication is useful in improving various gastrointestinal-related problems.
○ Adults Usually, 2 tablets are administered orally twice daily, in the morning and before bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily before bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and before bedtime. The same dosage applies to concomitant treatment of ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily before bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily or 4 tablets once daily before bedtime for 8 weeks. However, the dose may be increased to 4 tablets 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 2 tablets 3 times daily, and increase the dose as needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Pre-anesthetic medication (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.
This medication should not be used in patients receiving dialysis treatment or those allergic to this medication or its components. It is also not safe to administer to patients with a history of acute porphyria. Administration should be avoided in patients with impaired renal function, those who have undergone upper gastrointestinal surgery, pregnant women or women with a possibility of pregnancy, premature infants, and neonates, as well as patients on potassium-restricted diets. Patients with impaired liver function, a history of drug allergies, the elderly, and patients with a history of renal dysfunction should use this medication with caution. Extra care should be taken if it is used in conjunction with non-steroidal anti-inflammatory drugs, and patients with gastric ulcers or middle-aged patients with newly appeared dyspeptic symptoms should use it only after excluding the possibility of gastric cancer. Patients with gastric or duodenal ulcers infected with Helicobacter pylori should undergo eradication therapy. Careful monitoring is required for severely ill patients in intensive care, hypophosphatemia patients, and those with swallowing difficulties. This drug can rarely cause severe allergic reactions such as anaphylactic shock; therefore, symptoms should be closely monitored during administration. Allergic reactions such as skin rash, urticaria, angioedema, fever, bronchospasm, and hypotension may occur, and if any of these symptoms appear, the use should be immediately discontinued. Rarely reported side effects include decreased blood cell count, liver dysfunction, arrhythmia, gastrointestinal symptoms, and psychiatric neurological symptoms; any abnormal symptoms should be discussed with healthcare providers. Long-term use is not recommended, and it is safest to use the minimal effective dose while closely observing the treatment progress. Particularly in the elderly or immunocompromised patients, the risk of pneumonia may increase; caution is advised. Dizziness or drowsiness may occur, so driving or operating hazardous machinery is advised against. This medication may interact with other drugs, so if there are any concomitant medications, it is essential to inform healthcare providers. Caution is particularly needed when combined with anticoagulants, certain antibiotics, or anticonvulsants, and the dosage intervals may need adjustment. Pregnant or breastfeeding women should not use this medication, and safety in children has not been established, so use is not recommended. In case of overdose, emergency measures such as vomiting or gastric lavage are necessary, and in some cases blood dialysis may be used to remove the drug. This medication can reduce gastric acid secretion and promote bacterial growth in the gastrointestinal tract, so long-term use may necessitate ophthalmic examinations.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure, and it is best to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.
White, round, film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Jeongwoo Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.